Disproportional response: a small company's current business is visibly outgrowing its own size
The model's full reasoning — Q3 2022 call → NOWe need to answer YES or NO based on the transcript. The question asks: does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup — that is, does management describe current activity, demand, or commitments arriving at a scale that is large relative to how small the company still is, so that the reported results look like the early portion of something meaningfully bigger rather than a full picture of the business? We need to look for management's own words conveying a disproportion between the size of the company and the size of what is currently arriving or being committed to it. This could be in terms of loans, deposits, investment banking, etc. In the transcript, Chris Gorman says: "We continue to see more activity moving onto our balance sheet. In the third quarter, we raised a record $39 billion for our clients, of which 23% was retained on our balance sheet, well above our long-term average of 18%." That is a record amount, but is it large relative to the company's size? The company has $114 billion in average loans, $144 billion in deposits. $39 billion raised is significant but not necessarily "outgrowing" the company. Also, they mention "we have been very deliberate and intentional in managing with a long-term perspective." They talk about the $1.2 billion benefit from re-pricing swaps and treasuries. That is a future benefit, not current activity. The question is about current activity being disproportionately large relative to the company's smallness. The company is a large regional bank, not small. They have $114 billion in loans, $144 billion in deposits. They are not a small company. The question asks if the company is small relative to what is happening. That doesn't seem to be the case. Management does not convey that they are small. They talk about "targeted scale sectors" and "growing relationships" but nothing about being small. Also, the question says: "Answer NO if the company is large relative to what it describes, or already a leading participant with no meaningful disproportion ahead of it." KeyCorp is a large bank, a leading participant. So likely NO. Check for any explicit statement of disproportion. They mention "we raised a record $39 billion" but that is not necessarily disproportionate to their size.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
VNRX · Q1 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management explicitly describing the Heska deal (already signed and with $10M upfront received) as a long-term, multi-year commitment that will generate ongoing kit/component revenue "significantly greater" than the $28M milestones, with "millions of tests" expected each year — all while repeatedly noting the company is "not a big company" and that this is "the beginning of our commercial journey" after 12 years of R&D. They contrast this with their tiny current revenue ($114k) and cash position, framing the new activity as disproportionately large relative to their size.
TMCI · Q2 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES Management explicitly describes the business as outgrowing its current setup in present-tense terms: they are “once again in the process of relocating to a larger headquarters facility” to meet “increased requirements” for training, R&D, warehousing, and infrastructure; the direct sales force has grown 52% to 123 quota-carrying reps and is already trending above the year-end 70% direct mix goal; surgeon penetration has reached 20% of the estimated 10,000 U.S. foot-and-ankle surgeons while procedure penetration is 4.6% of the 450,000 annual U.S.
KOPN · Q4 2023 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management describing current activity (a $55 million backlog, a $20.5 million new order, follow-on orders, and tripled weapon-site volume expected in 2024) as large relative to the company’s still-small size and setup. They explicitly note the backlog is a “record level 10 years,” that they had to extend the holiday shutdown and retool the plant for a “significant increase in production,” and that they are “buying to that level of volume today” while remaining conservative on guidance.